Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
President Joe Biden on Wednesday announced a proposed rule by the Federal Trade Commission to ban any hidden and bogus junk fees, which can mask the total cost of concert tickets, hotel rooms and utility bills.
The challenges of finding a job are different for everyone, especially for the neurodiverse community, which often includes those who have autism or ADHD. The docuseries Ready4Work follows a job seeker who is neurodivergent.
An organizer estimated that more than 300 locations have been impacted, while a Walgreens spokesman said no more than a dozen pharmacies saw disruptions.
